[Clinical evaluation of the tumor marker CA125 in ovarian tumor (a cooperative study among 8 institutions)].
作者信息
Kato T, Nishimura H, Hamai J, Yamabe T, Nakajima H, Nakano T, Noda K, Teshima K, Suzuki H, Ueda G
出版信息
Nihon Gan Chiryo Gakkai Shi. 1985 Dec 20;20(10):2338-45.
PMID:3007640
Abstract
摘要
相似文献
1
[Clinical evaluation of the tumor marker CA125 in ovarian tumor (a cooperative study among 8 institutions)].[肿瘤标志物CA125在卵巢肿瘤中的临床评估（8家机构合作研究）]
Nihon Gan Chiryo Gakkai Shi. 1985 Dec 20;20(10):2338-45.
2
[A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers].[一项关于定位及血清数据的研究；卵巢癌中的四种肿瘤标志物（CA125、CA19-9、CEA和TPA）]
Nihon Gan Chiryo Gakkai Shi. 1990 Jan 20;25(1):47-54.
3
4
[Relationship between serum levels and immunohistological tissue levels of CA 125 and CEA in epithelial ovarian cancers: its implications for tumor cell type specificity].[上皮性卵巢癌中CA 125和CEA的血清水平与免疫组织化学组织水平之间的关系：其对肿瘤细胞类型特异性的影响]
Nihon Sanka Fujinka Gakkai Zasshi. 1986 Sep;38(9):1595-604.
5
Immunological reactivity of mucinous and serous ovarian adenocarcinomas.黏液性和浆液性卵巢腺癌的免疫反应性。
Cancer Detect Prev. 1986;9(3-4):347-58.
6
Antigen CA125 in tumor tissue and serum from patients with adenocarcinoma of the ovary.
Gynecol Oncol. 1988 Jul;30(3):342-6. doi: 10.1016/0090-8258(88)90248-x.
7
Comparative measurement of ovarian carcinoma antigen and carcinoembryonic antigen in the serum of ovarian cancer.卵巢癌患者血清中卵巢癌抗原与癌胚抗原的比较测定
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi. 1987 Aug;20(3):190-7.
8
[The clinical significance of CA125 in patients with gynecological tumors--a comparative study on CA125 and other tumor markers].
Gan No Rinsho. 1985 May;31(5):544-8.
9
[Clinical value of a new serum tumor marker CA602 in ovarian cancers].新型血清肿瘤标志物CA602在卵巢癌中的临床价值
Nihon Gan Chiryo Gakkai Shi. 1990 Jul 20;25(7):1454-60.
10
[Clinical significance of new tumor marker CA 125 in gynecological cancer--particularly usefulness in diagnosis of ovarian cancer].
Nihon Sanka Fujinka Gakkai Zasshi. 1984 Nov;36(11):2121-8.
Zotero 插件